Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,577.68
(
-0.71%
)
US TECH 100
23,652.40
(
-0.60%
)
Dow Jones
45,857.91
(
-0.79%
)
Brent Oil
108.31
(
1.62%
)
Bitcoin
69,291.58
(
-2.74%
)
News Focus
News Focus
Post# of 257259
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 842
Posts 122798
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 165092

Tuesday, 08/20/2013 8:39:50 AM

Tuesday, August 20, 2013 8:39:50 AM

Post# of 257259
XOMA sells 8.7M* shares @$3.62/sh, raising $29.7M* in net proceeds:

http://finance.yahoo.com/news/xoma-announces-pricing-27-5-123031775.html

The financing transaction was fully expected (#msg-90794646), but I figured XOMA would opt for a somewhat larger offering. After this raise, XOMA may not have enough cash to see the EYEGUARD uveitis program to completion while also running Gevokizumab PoC trials in other indications.

*Assuming exercise of underwriter’s option.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now